Former CEO of pharma firm and his family to receive Covishie
Now open: Certificate Course in Management of Covid-19 by Govt. Of Gujarat and PlexusMDKnow more...Now open: Certificate Course in Management of Covid-19 by Govt. Of Gujarat and PlexusMDKnow more...
Get authentic, real-time news that helps you fight COVID-19 better.
Install PlexusMD App for doctors. It's free.
Six people, including a former CEO of a pharmaceutical firm and his family, were administered a dose of the Oxford-AstraZeneca Covid-19 vaccine candidate on 27 August.

Here are key updates of Oxford Covid vaccine trial in India:

• The phase II clinical trial of the Oxford covid vaccine in India started on 26 August at Pune's Bharti Vidyapeeth's Medical College and Hospital.

• Two volunteers, aged 32 and 48, were given a shot of the 'Covishield' vaccine on 26 Aug.

• "Our medical team is in touch with the two volunteers and both are fine. They do not have any pain, fever, injection-site reaction or systemic illness post-vaccination," Bharti Vidyapeeth's Medical College's deputy director Dr Jitendra Oswal told PTI.

• The vaccine dose will be repeated on both the volunteers after one month.

• The phase-2 trial of Oxford covid vaccine will be conducted on 100 volunteers at some sites across the country.

• After that 1,500 people will be administered the (potential) vaccine across the country in the next phase, depending on the results of the phase II trial.

The vaccines are being manufactured by the Pune-based Serum Institute of India (SII) who partnered with British-Swedish pharma company AstraZeneca to manufacture covid vaccines developed by Oxford University.

Dr. T●●●●z H●●●●●●i and 2 other likes this
Dr. P●●●●●●●●a S N●●k
Dr. P●●●●●●●●a S N●●k Occupational Medicine
Ita injection site rwaction , not side reaction!
Aug 28, 2020Like